Decline in platelet count and long-term post-PCI ischemic events: Implication of the intra-aortic balloon pump

Vascular Pharmacology

Volumn 60, Issue 1, 2014, Pages 25-31

  Schiariti, Michele ^a,b   Saladini, Patrizia ^b   Cuturello, Domenico ^a   Iannetta, Loredana ^a,b   Torromeo, Concetta ^a   Puddu, Paolo Emilio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Sant'Anna Hospital   (Italy)

Author keywords

Ischemic events; Outcome; PCI; Platelet count; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; EPTIFIBATIDE; HEPARIN; TICLOPIDINE; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; ECG ABNORMALITY; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTRAAORTIC BALLOON PUMP; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SHOCK; STABLE ANGINA PECTORIS; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME OF DEATH; UNSTABLE ANGINA PECTORIS;

ISCHEMIC EVENTS; OUTCOME; PCI; PLATELET COUNT; THROMBOCYTOPENIA;

AGED; FEMALE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; THROMBOCYTOPENIA;

EID: 84892539996     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.11.002     Document Type: Article

References (32)

1. E.P.I.S.T.E.N.T.Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998, 352:87-92.
2. Kereiakes D.J., Berkowitz S.D., Lincoff A.M., Tcheng J.E., Wolski K., Achenbach R., et al. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade. Am Heart J 2000, 140:74-80.
3. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997, 336:1689-1696.
4. González-Ponte M.L., González-Ruiz M., Duvós E., Gutiérrez-Iñiguez M.A., Olalla J.I., Conde E. Atorvastatin-induced severe thrombocytopenia. Lancet 1998, 352:1284.
5. Groneberg D.A., Barkhuizen A., Jeha T. Simvastatin-induced thrombocytopenia. Am J Hematol 2001, 67:277.
6. McCarthy L.J., Porcu P., Fausel C.A., Sweeney C.J., Danielson C.F. Thrombotic thrombocytopenic purpura and simvastatin. Lancet 1998, 352:1284-1285.
7. Grosbois B., Milton D., Beneton C., Jacomy D. Thrombocytopenia induced by angiotensin converting enzyme inhibitors. Br Med J 1989, 298:189-190.
8. Guo Y.L., Li J.J., Yuan J.Q., Qin X.W., Zheng X., Mu C.W., et al. Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration. World J Cardiol 2010, 2:160-162.
9. Vonderheide R.H., Thadhani R., Kuter D.J. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med 1998, 105:27-32.
10. De Labriolle A., Bonello L., Lemesle G., Roy P., Steinberg D.H., Xue Z., et al. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J 2010, 31:1079-1087.
11. Harrington R.A., Sane D.C., Califf R.M., Sigmon K.N., Abbottsmith C.W., Candela R.J., et al. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1994, 23:891-898.
12. Konkle B.A. Percutaneous interventions in the coagulopathic patient. Semin Interv Radiol 2005, 22:88-94.
13. Konkle B.A. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program 2011, 2011:391-396.
14. McClure M.W., Berkowitz S.D., Sparapani R., Tuttle R., Kleiman N.S., Berdan L.G., et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation 1999, 99:2892-2900.
15. Berkowitz S.D., Sane D.C., Sigmon K.N., Shavender J.H., Harrington R.A., Tcheng J.E., et al. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischaemic Complications (EPIC) Study Group. J Am Coll Cardiol 1998, 32:311-319.
16. Nikolsky E., Sadeghi H.M., Effron M.B., Mehran R., Lansky A.J., Na Y., et al. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2005, 96:474-481.
17. Wang T.Y., Ou F.S., Roe M.T., Harrington R.A., Ohman E.M., Gibler W.B., et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation 2009, 119:2454-2462.
18. Caixeta A., Dangas G.D., Mehran R., Feit F., Nikolsky E., Lansky A.J., et al. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Am Heart J 2011, 161:298-306.
19. Schiariti M., Saladini A., Missiroli B., Papalia F., Cuturello D., Puddu P.E., et al. Safety of downstream high-dose tirofiban bolus among 1578 patients undergoing percutaneous coronary intervention: the Sant'ANna TIrofiban Safety study. J Cardiovasc Med 2010, 11:250-259.
20. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial. Third universal definition of myocardial infarction. Eur Heart J 2012, 33:2551-2567.
21. Dasgupta H., Blankenship J.C., Wood G.C., Frey C.M., Demko S.L., Menapace F.J. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis. Am Heart J 2000, 140:206-211.
22. Eikelboom J.W., Anand S.S., Mehta S.R., Weitz J.I., Yi C., Yusuf S. Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischaemic Syndromes (OASIS-2) study. Circulation 2001, 103:643-650.
23. Stone G.W., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008, 358:2218-2230.
24. Shenoy C., Orshaw P., Devarakonda S., Harjai K.J. Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia in an unselected population. J Interv Cardiol 2009, 22:156-162.
25. Biino G., Santimone I., Minelli C., Sorice R., Frongia B., Traglia M., et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PLoS One 2013, 8:e54289.
26. van der Bom J.G., Heckbert S.R., Lumley T., Holmes C.E., Cushman M., Folsom A.R., et al. Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost 2009, 7:399-405.
27. Puddu P.E., Menotti A., Tolonen H., Nedeljkovic S., Kafatos A. Determinants of 40-year all-cause mortality in the European cohorts of the Seven Countries Study. Eur J Epidemiol 2011, 26:595-608.
28. Bream-Rouwenhorst H.R., Hobbs R.A., Horwitz P.A. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Interv Cardiol 2008, 21:350-356.
29. Zimarino M., Corazzini A., Tatasciore A., Marazia S., Torge G., Di Iorio C., et al. Defective recovery of QT dispersion predicts late cardiac mortality after percutaneous coronary intervention. Heart 2011, 97:466-472.
30. Puddu P.E., Jouve R., Torresani J., Jouve A. QT interval and primary ventricular fibrillation in acute myocardial infarction. Am Heart J 1981, 101:118-120.
31. Puddu P.E., Bourassa M.G. Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 1986, 19:203-212.
32. Piccirillo G., Magnanti M., Matera S., Di Carlo S., De Laurentis T., Torrini A., et al. Age and QT variability index during free breathing, controlled breathing and tilt in patients with chronic heart failure and healthy control subjects. Transl Res 2006, 148:72-78.